Article Versions Notes

Appleton KM, Palsuledesai CC, Misek SA, Blake M, Zagorski J, Gallo KA, Dexheimer TS, Neubig RR. Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines. Cancers. 2021; 13(9):2012. https://doi.org/10.3390/cancers13092012

Appleton, Kathryn M., Charuta C. Palsuledesai, Sean A. Misek, Maja Blake, Joseph Zagorski, Kathleen A. Gallo, Thomas S. Dexheimer, and Richard R. Neubig. 2021. "Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines" Cancers 13, no. 9: 2012. https://doi.org/10.3390/cancers13092012

Appleton, K. M., Palsuledesai, C. C., Misek, S. A., Blake, M., Zagorski, J., Gallo, K. A., Dexheimer, T. S., & Neubig, R. R. (2021). Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines. Cancers, 13(9), 2012. https://doi.org/10.3390/cancers13092012